TwinBeech Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,841
Closed -$657K 730
2025
Q4
$657K Buy
+6,841
New +$665K 0.05% 369
2025
Q2
Sell
-25,611
Closed -$2.3M 864
2025
Q1
$2.3M Sell
25,611
-535,791
-95% -$47.9M 0.04% 368
2024
Q4
$44.8M Buy
+561,402
New +$48.6M 0.77% 37
2023
Q3
Sell
-98,915
Closed -$8.71M 802
2023
Q2
$8.71M Buy
+98,915
New +$8.52M 0.17% 163
2023
Q1
Sell
-190,002
Closed -$14.8M 780
2022
Q4
$14.8M Sell
190,002
-10,408
-5% -$844K 0.28% 103
2022
Q3
$16.2M Buy
200,410
+29,329
+17% +$2.64M 0.43% 67
2022
Q2
$15.4M Buy
+171,081
New +$17.3M 0.69% 42
2022
Q1
Sell
-83,369
Closed -$8.63M 651
2021
Q4
$8.63M Buy
+83,369
New +$9.65M 0.49% 57
2020
Q4
Sell
-24,417
Closed -$2.54M 546
2020
Q3
$2.54M Buy
+24,417
New +$2.45M 0.55% 51
2020
Q1
Sell
-26,354
Closed -$2.99M 404
2019
Q4
$2.99M Buy
+26,354
New +$2.89M 0.87% 22

Other funds holding MDT

TwinBeech Capital's MDT Position: Q1 2026 in Review

TwinBeech Capital sold out of Medtronic (MDT) in Q1 2026, closing a stake of 6,841 shares — an estimated $657K sold.

TwinBeech Capital first reported a position in MDT in Q4 2019 and held it in 10 quarters. The position peaked at $44.8M in Q4 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • TwinBeech Capital reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • TwinBeech Capital sold 6,841 Medtronic shares in Q1 2026, an estimated $657K.
  • TwinBeech Capital first reported a position in Medtronic in Q4 2019 and held it in 10 quarters.
  • TwinBeech Capital's Medtronic position peaked at $44.8M in Q4 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.